Dare Bioscience (DARE)
(Delayed Data from NSDQ)
$0.44 USD
-0.01 (-1.27%)
Updated Jun 13, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
Dare Bioscience, Inc. [DARE]
Reports for Purchase
Showing records 101 - 120 ( 213 total )
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Virtual Marketing by Analyst Zegbeh Jallah Begins @ 12pm ET Tomorrow
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
On Track for BV-1 NDA This Quarter; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
1Q21 - Valuation Remains Attractive for a Large Women''s Health Pipeline
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
4Q20 Update - Multiple Catalysts Reaffirmed for Our 2021 Top Pick
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Eventful 2021 Shaping Up With Plentiful Optionality; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Dare''s Making Significant Pipeline Progress - Topline Datasets by YE2021
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare- Please Join Our Virtual 33rd Annual ROTH Conference on March 15 - 17th
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Filling Gaps in Women?s Health; Initiate With Buy and a $5 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Phase 3 Data in Bacterial Vaginosis Hits The Mark. Increasing PT to $9.
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
BUY: BV1 Top-Line Data by YE Could Be Transformative
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
3Q20 Update - Get Ready for DAREBV1 Topline Results by YE2020
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z